BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2021 2:18:21 AM | Browse: 340 | Download: 588
 |
Received |
|
2021-05-30 22:01 |
|
Peer-Review Started |
|
2021-05-30 22:05 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-14 16:40 |
|
Revised |
|
2021-07-21 22:38 |
|
Second Decision |
|
2021-09-22 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-09-23 07:25 |
|
Articles in Press |
|
2021-09-23 07:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-18 11:41 |
|
Typeset the Manuscript |
|
2021-11-12 05:59 |
|
Publish the Manuscript Online |
|
2021-11-17 02:18 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Minireviews |
| Article Title |
Breast cancer in schizophrenia could be interleukin-33-mediated
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Milica M Borovcanin and Katarina Vesic |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Science and Technological Development of the Republic of Serbia |
175069 |
| Faculty of Medical Sciences, University of Kragujevac |
JP15-05 |
|
| Corresponding Author |
Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, University of Kragujevac, Faculty of Medical Sciences, 69 Svetozara Markovica St, Kragujevac 34000, Serbia. milicaborovcanin@medf.kg.ac.rs |
| Key Words |
Interleukin-33; Schizophrenia; Breast cancer; Neurodegeneration |
| Core Tip |
The frequent occurrence of breast carcinoma in female patients with schizophrenia could indicate a specific immunological perturbation in both diseases. A common denominator could be interleukin-33 (IL-33). In this review article, we aim to describe the IL-33/suppressor of tumorigenicity 2 axis as a crossroad in schizophrenia-breast cancer comorbidity. Considering that raloxifene could be tissue-specific and improve cognition and that tamoxifen resistance in breast carcinoma could be improved by strategies targeting IL-33, these selective estrogen receptor modulators could be useful in complementary treatment. These observations could guide further somatic, as well as psychiatric therapeutical protocols by incorporating what is known about immunity in schizophrenia. |
| Publish Date |
2021-11-17 02:18 |
| Citation |
Borovcanin MM, Vesic K. Breast cancer in schizophrenia could be interleukin-33-mediated. World J Psychiatr 2021; 11(11): 1065-1074 |
| URL |
https://www.wjgnet.com/2220-3206/full/v11/i11/1065.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v11.i11.1065 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
